BRADFORD S. GOODWIN - Corporate Board Profile

RIGEL PHARMACEUTICALS INC

Filing Date	Source Excerpt
2007-03-26	Bradford S. Goodwin, age 52, joined us as a director in January 2007. Mr. Goodwin is currently a director of PDL BioPharma and until its sale in early 2007 he was also the Chairman of the Board of CoTherix, Inc., a public-traded company focused on pulmonary arterial hypertension. ... No other options may be granted at any time under the Directors' Plan. ... Bradford S. Goodwin Fees Earned or Paid in Cash ($) 0 Option Awards ($) 0 Total ($) 0
2008-04-08	Bradford S. Goodwin, age 53, joined us as a director in January 2007. ... The Audit Committee comprises three directors: Messrs. Goodwin and Renton and Dr. Sherwin. Effective with his appointment in January 2007, Mr. Goodwin joined the Audit Committee, replacing Mr. Lyons. ... The following table shows for the fiscal year ended December 31, 2007 certain information with respect to the compensation of all non-employee directors of the Company: Bradford S. Goodwin $57,000 Fees Earned or Paid in Cash, $151,886 Option Awards, Total $208,886.
2009-04-15	Bradford S. Goodwin, age 54, joined us as a director in January 2007. ... The following three directors are the members of the Audit Committee: Messrs. Goodwin and Renton and Dr. Sherwin, all of whom were on the Audit Committee for all of fiscal year 2008. ... For services provided in 2008, each non-employee director of Rigel received a yearly retainer of $30,000, ... In the fiscal year ended December 31, 2008, the total cash compensation earned by non-employee directors was $178,390.
2010-04-12	Bradford S. Goodwin, age 55, joined us as a director in January 2007. The Nominating and Corporate Governance Committee concluded that Mr. Goodwin should continue to serve as a director of Rigel in part due to his financial expertise and extensive public accounting and corporate governance experience, as well as his experience sitting on the audit committees of other public companies. Mr. Goodwin is currently President and CEO of Keren Pharmaceutical, Inc. and the non-executive Chairman of Facet Biotech Corporation. In addition to serving on the Facet Biotech board, he currently serves on the Boards of Directors of NeurogesX, Inc. Mr. Goodwin's prior public company board service includes PDL BioPharma, Inc. from 2006 to 2008, CoTherix, Inc. from 2004 until 2007 and Novacea, Inc. from 2002 until 2006. From 2001 to 2006, he was Chief Executive Officer and Director of Novacea, Inc., a publicly-held biopharmaceutical company focused on in-licensing, developing and commercializing novel therapies for cancer. Prior to Novacea, Mr. Goodwin was President, Chief Operating Officer and Founder of Collabra Pharma, Inc., a company focused on pharmaceutical product licensing and development. Before starting Collabra, he held various senior executive positions with Genentech, Inc., including Vice President of Finance. After becoming a CPA while working as an auditor at PricewaterhouseCoopers, he served on expert advisory committees of the American Institute of Certified Public Accountants, the Financial Accounting Standards Board and the International Accounting Standards Board. Mr. Goodwin holds a B.S. in Business Administration from the University of California, Berkeley. DIRECTOR COMPENSATION FOR FISCAL YEAR 2009 The following table shows for the fiscal year ended December 31, 2009 certain information with respect to the compensation of all non-employee directors of the Company: Bradford S. Goodwin $59,500 Fees Earned or Paid in Cash Option Awards $59,159 Total $118,659
2011-04-04	Bradford S. Goodwin, age 56, joined us as a director in January 2007. The Board concluded that Mr. Goodwin continues to be a valuable member of the Board in part due to his financial expertise and extensive public accounting and corporate governance experience, as well as his experience sitting on the audit committees of other public companies. ... The following table shows the compensation of all non-employee directors of the Company for the fiscal year ended December 31, 2010: Bradford S. Goodwin $63,000 Option Awards $75,390 Total $138,390
2012-04-12	Bradford S. Goodwin, age 57, joined us as a director in January 2007. ... The Board has four standing committees: ... Audit Committee ... The following three directors are the members of the Audit Committee: Messrs. Goodwin and Renton and Dr. Sherwin. ... For services provided in 2011, each non-employee director of Rigel received a yearly retainer of $30,000, ... In the fiscal year ended December 31, 2011, the total cash compensation earned by non-employee directors was $375,750. ... The following table shows the compensation of all non-employee directors of the Company for the fiscal year ended December 31, 2011: ... Bradford S. Goodwin ... Total $155,299.
2013-04-03	Bradford S. Goodwin, age 58, joined us as a director in January 2007. The Board concluded that Mr. Goodwin continues to be a valuable member of the Board in part due to his financial expertise and extensive public accounting and corporate governance experience, as well as his experience sitting on the audit committees of other public companies. ... The following table shows the compensation of all non-employee directors of the Company for the fiscal year ended December 31, 2012: Bradford S. Goodwin 67,000 76,760 143,760 Gary A. Lyons 65,000 76,760 141,760 Walter H. Moos, Ph.D. 65,000 76,760 141,760 Hollings C. Renton 57,000 76,760 133,760 Peter S. Ringrose, Ph.D. 67,500 76,760 144,260 Stephen A. Sherwin, M.D. 72,000 76,760 148,760
2014-04-08	Bradford S. Goodwin, age 59, joined us as a director in January 2007. The Board concluded that Mr. Goodwin continues to be a valuable member of the Board in part due to his financial expertise and extensive public accounting and corporate governance experience, as well as his experience sitting on the audit committees of other public companies. ... On May 15, 2013, pursuant to the Directors' Plan, we granted options to purchase 15,000 shares of common stock to Bradford S. Goodwin, each at an exercise price of $4.87 per share. These options vest in 12 equal monthly installments beginning on the grant date. ... The following table shows the compensation of all non-employee directors of the Company for the fiscal year ended December 31, 2013: Bradford S. Goodwin Fees Earned or Paid in Cash ($) 67,000 Option Awards ($) 51,477 Total ($) 118,477
2015-03-30	Bradford S. Goodwin, age 60, joined us as a director in January 2007. ... Mr. Goodwin was appointed to and made Chairperson of the Finance Committee effective April 1, 2015. ... The following table shows the compensation of all non-employee directors of the Company for the fiscal year ended December 31, 2014: ... Bradford S. Goodwin 67,000 70,326 137,326 ...
2016-03-28	Bradford S. Goodwin, age 61, joined us as a director in January 2007. ... The following table shows the compensation of all non-employee directors of the Company for the fiscal year ended December 31, 2015: ... Bradford S. Goodwin Fees Earned or Paid in Cash $74,500, Option Awards $158,400, Total $232,900.
2017-03-29	Bradford S. Goodwin, age 62, joined us as a director in January 2007. ... Mr. Goodwin was selected to serve as a member of the Board ... The following table shows the compensation of all non-employee directors of the Company for the fiscal year ended December 31, 2016: Bradford S. Goodwin Fees Earned or Paid in Cash $77,000, Option Awards $57,148, Total $134,148.
2018-04-04	Bradford S. Goodwin, age 63, joined us as a director in January 2007. ... The following table shows the compensation of all non-employee directors of the Company for the fiscal year ended December 31, 2017: Bradford S. Goodwin Fees Earned or Paid in Cash $77,000 Option Awards $64,708 Total $141,708.
2019-04-09	Bradford S. Goodwin, age 64, joined us as a director in January 2007. ... The following three directors are the current members of the Audit Committee: Mr. Goodwin, Mr. Katkin and Mr. Lapointe. ... The following three directors are the members of the Compensation Committee: Mr. Lyons, Mr. Katkin and Dr. Moos. ... The following table shows the compensation of all non-employee directors of the Company for the fiscal year ended December 31, 2018: Bradford S. Goodwin 82,000 fees earned in cash, 103,664 option awards, total 185,664.
2020-04-01	Bradford S. Goodwin, age 65, joined us as a director in January 2007. ... The following three directors are the current members of the Audit Committee: Mr. Goodwin, Mr. Katkin and Mr. Lapointe. Mr. Goodwin serves as Chair. ... The following three directors were members of the Finance Committee for all of 2019: Mr. Goodwin, Mr. Lyons and Mr. Rodriguez. ... For services provided in 2019, each non-employee director received, paid on a quarterly basis for quarters served, a yearly retainer of $50,000. ... The following table shows the compensation of all non-employee directors of the Company for the fiscal year ended December 31, 2019: Bradford S. Goodwin Fees Earned or Paid in Cash $77,000, Option Awards $22,917, Total $99,917.
2021-04-06	Bradford S. Goodwin, age 66, joined us as a director in January 2007. ... The following three directors are the current members of the Audit Committee: Mr. Goodwin ... The following three directors were members of the Finance Committee for all of 2020: Mr. Goodwin, Mr. Lyons and Mr. Rodriguez. ... The following table shows the compensation of all non-employee directors of the Company for the fiscal year ended December 31, 2020: Bradford S. Goodwin Fees Earned or Paid in Cash $77,000, Option Awards $62,695, Total $139,695.
2022-04-05	The Board presently has ten members, two of which were added in 2021, namely, Dr. Alison Hannah and Ms. Kamil Ali-Jackson. In 2022, the Board determined that it is in the best interests of the Company and its stockholders to return the size of the Board to eight directors. Accordingly, two of our current directors, Messrs. Goodwin and Katkin, were not nominated for reelection at the Annual Meeting. We thank Messrs. Goodwin and Katkin for their service to the Company. ... The following directors are currently members of the Audit Committee: Mr. Goodwin, Mr. Katkin and Mr. Lapointe. Mr. Goodwin serves as Chair.